Global Orphan Drugs Competitive Landscape Professional Research Report 2024

Global Orphan Drugs Competitive Landscape Professional Research Report 2024



Research Summary

Orphan drugs, also known as orphan medicinal products, are pharmaceutical substances developed to diagnose, prevent, or treat rare diseases and conditions that affect a small percentage of the population. These diseases, often referred to as orphan diseases, are typically life-threatening or chronically debilitating and can be genetic, infectious, or autoimmune in nature. Due to the limited prevalence of these conditions, traditional pharmaceutical companies may have little incentive to invest in developing treatments. Orphan drug status is granted by regulatory agencies to incentivize pharmaceutical companies to research and develop therapies for these rare diseases. This designation may include benefits such as extended market exclusivity, tax incentives, and reduced regulatory requirements, encouraging the development of drugs that might otherwise not be economically viable. Orphan drugs have played a significant role in improving the quality of life and life expectancy of individuals with rare diseases.

According to DIResearch's in-depth investigation and research, the global Orphan Drugs market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Orphan Drugs include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, AbbVie, Biogen, Eli Lilly etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Orphan Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orphan Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Orphan Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orphan Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Orphan Drugs Include:

Bristol-Myers Squibb

Roche

Novartis

Johnson & Johnson

Pfizer

Amgen

Sanofi

AstraZeneca

Takeda

Vertex Pharmaceuticals

AbbVie

Biogen

Eli Lilly

Orphan Drugs Product Segment Include:

Oncology

Pulmonary

Neurology

Hematology

Endocrinology

Cardio-vascular

Metabolic Disorders

Others

Orphan Drugs Product Application Include:

Baby and Child

Teenager

Adult

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Orphan Drugs Industry PESTEL Analysis

Chapter 3: Global Orphan Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Orphan Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Orphan Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Orphan Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Orphan Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Orphan Drugs Market Overview
1.1 Product Definition and Statistical Scope
1.2 Orphan Drugs Product by Type
1.2.1 Global Orphan Drugs Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Oncology
1.2.3 Pulmonary
1.2.4 Neurology
1.2.5 Hematology
1.2.6 Endocrinology
1.2.7 Cardio-vascular
1.2.8 Metabolic Disorders
1.2.9 Others
1.3 Orphan Drugs Product by Application
1.3.1 Global Orphan Drugs Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Baby and Child
1.3.3 Teenager
1.3.4 Adult
1.3.5 Others
1.4 Global Orphan Drugs Market Revenue Analysis (2019-2030)
1.5 Orphan Drugs Market Development Status and Trends
1.5.1 Orphan Drugs Industry Development Status Analysis
1.5.2 Orphan Drugs Industry Development Trends Analysis
2 Orphan Drugs Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Orphan Drugs Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Orphan Drugs Market Analysis by Regions
4.1 Orphan Drugs Overall Market: 2023 VS 2024 VS 2030
4.2 Global Orphan Drugs Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Orphan Drugs Revenue and Market Share by Region (2019-2024)
4.2.2 Global Orphan Drugs Revenue Forecast by Region (2025-2030)
5 Global Orphan Drugs Market Size by Type and Application
5.1 Global Orphan Drugs Market Size by Type
5.2 Global Orphan Drugs Market Size by Application
6 North America
6.1 North America Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Orphan Drugs Market Size by Type
6.4 North America Orphan Drugs Market Size by Application
6.5 North America Orphan Drugs Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Orphan Drugs Market Size by Type
7.4 Europe Orphan Drugs Market Size by Application
7.5 Europe Orphan Drugs Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Orphan Drugs Market Size by Type
8.4 China Orphan Drugs Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Orphan Drugs Market Size by Type
9.4 APAC (excl. China) Orphan Drugs Market Size by Application
9.5 APAC (excl. China) Orphan Drugs Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Orphan Drugs Market Size by Type
10.4 Latin America Orphan Drugs Market Size by Application
10.5 Latin America Orphan Drugs Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Orphan Drugs Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Orphan Drugs Market Size by Type
11.4 Middle East & Africa Orphan Drugs Market Size by Application
11.5 Middle East & Africa Orphan Drugs Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Orphan Drugs Market Revenue by Key Manufacturers (2020-2024)
12.2 Orphan Drugs Competitive Landscape Analysis and Market Dynamic
12.2.1 Orphan Drugs Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Bristol-Myers Squibb Orphan Drugs Product Portfolio
13.1.3 Bristol-Myers Squibb Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Roche
13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Roche Orphan Drugs Product Portfolio
13.2.3 Roche Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Novartis
13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Novartis Orphan Drugs Product Portfolio
13.3.3 Novartis Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Johnson & Johnson Orphan Drugs Product Portfolio
13.4.3 Johnson & Johnson Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Pfizer
13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Pfizer Orphan Drugs Product Portfolio
13.5.3 Pfizer Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Amgen
13.6.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Amgen Orphan Drugs Product Portfolio
13.6.3 Amgen Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Sanofi
13.7.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Sanofi Orphan Drugs Product Portfolio
13.7.3 Sanofi Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 AstraZeneca
13.8.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 AstraZeneca Orphan Drugs Product Portfolio
13.8.3 AstraZeneca Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Takeda
13.9.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Takeda Orphan Drugs Product Portfolio
13.9.3 Takeda Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Vertex Pharmaceuticals
13.10.1 Vertex Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Vertex Pharmaceuticals Orphan Drugs Product Portfolio
13.10.3 Vertex Pharmaceuticals Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 AbbVie
13.11.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 AbbVie Orphan Drugs Product Portfolio
13.11.3 AbbVie Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 Biogen
13.12.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Biogen Orphan Drugs Product Portfolio
13.12.3 Biogen Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.13 Eli Lilly
13.13.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Eli Lilly Orphan Drugs Product Portfolio
13.13.3 Eli Lilly Orphan Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Orphan Drugs Industry Chain Analysis
14.2 Orphan Drugs Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Orphan Drugs Typical Downstream Customers
14.4 Orphan Drugs Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings